1 week Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?The Motley Fool
Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has helped its earnings and its stock soar in recent times. It consists of the company’s weight loss drugs: Mounjaro, approved for t…
Biotech · Earnings · Eli Lilly (LLY) · NYSE · Pharmaceuticals
X